NTRK1 and cancer: Cuproptosis molecules activated several signaling pathways, including the cell cycle, receptor tyrosine kinase, and hormone AR, and inhibited epithelial–mesenchymal transition (EMT), apoptosis, and DNA damage response in pan‐cancer (Figure S8A).